参考文献/References:
[1] ZHANG Tai,ZHANG Beihua,TIAN Wende,et al.Trends in gastroesophageal reflux disease research: A bibliometric and visualized study[J].Front Med(Lausanne),2022,9:994534.DOI:10.3389/fmed.2022.994534.
[2] GYAWALI C P,YADLAPATI R,FASS R,et al.Updates to the modern diagnosis of GERD: Lyon consensus 2.0[J].Gut,2024,73(2):361-371.DOI:10.1136/gutjnl-2023-330616.
[3] KNOTTS R M,YADLAPATI R.Personalized approach to the management of GERD: GI perspective[J].Foregut,2021,1(2):100-105.DOI:10.1177/26345161211046623.
[4] DUNBAR K B.Gastroesophageal reflux disease[J].Annals of Internal Medicine,2024,177(8):ITC113-ITC128.DOI:10.1055/s-2006-939868.
[5] BOULTON K H A,DETTMAR P W.A narrative review of the prevalence of gastroesophageal reflux disease(GERD)[J].Annals of Esophagus,2021,5:1-10.DOI:10.21037/aoe-20-80.
[6] RICHTER J E,RUBENSTEIN J H.Presentation andepidemiology of gastroesophageal reflux disease[J].Gastroenterology,2018,154(2):267-276.DOI:10.1053/j.gastro.2017.07.045.
[7] CLARRETT D M,HACHEM C.Gastroesophageal reflux disease(GERD)[J].Molecular Medicine,2018,115(3):214-218.DOI:10.1007/978-3-642-28753-4_100857.
[8] CHEN Changdan,ZHANG Wei,ZHENG Xiujin,et al.Analysis of the potential molecular mechanisms of asthma and gastroesophageal reflux disease[J].Journal of Asthma,2024,61(10):1222-1234.DOI:10.1080/02770903.2024.2334361.
[9] SHAH S C,PIAZUELO M B,KUIPERS E J,et al.AGA clinical practice update on the diagnosis and management of atrophic gastritis: Expert review[J].Gastroenterology,2021,161(4):1325-1332.DOI:10.1053/j.gastro.2021.06.078.
[10] LIU Zhiqiang,GAO Xiaoli,LIANG Lirong,et al.Prevalence, general and periodontal risk factors of gastroesophageal reflux disease in China[J].Journal of Inflammation Research,2023,16:235-244.DOI:10.2147/JIR.S395777.
[11] GHADEER H A A,ALABBAD Z E,ALSHAIKH S B,et al.Prevalence of gastroesophageal reflux disease and associated risk factors in the eastern region[J].Saudi Arabia Cureus,2021,13(11):e19599.DOI:10.7759/CUREUS.19599.
[12] TANVIR F,NIJJAR G S,AULAKH S K,et al.Gastroesophageal reflux disease: NewInsights and treatment approaches[J].Cureus,2024,16(8):e67654.DOI:10.7759/CUREUS.67654.
[13] EUSEBI L H,RATNAKUMARAN R,YUAN Yuhong,et al.Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: A meta-analysis[J].Gut,2018,67(3):430-440.DOI:10.1136/GUTJNL-2016-313589.
[14] LU Tailiang,LI Shaorong,ZHANG Jiamin,et al.Meta-analysis on the epidemiology of gastroesophageal reflux disease in China[J].World Journal of Gastroenterology,2022,28(45):6410-6420.DOI:10.3748/WJG.V28.I45.6410.
[15] CHIAPPETTA S,STIER C,GHANEM O M,et al.Perioperative interventions to prevent gastroesophageal reflux disease and marginal ulcers after bariatric surgery-an international experts’ survey[J].Obesity Surgery,2023,33(5):1449-1462.DOI:10.1007/S11695-023-06481-X.
[16] BENFANTE A,TOMASELLO A,CAPONETTO C,et al.Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities?[J].Journal of Asthma,2024,61(9):1083-1088.DOI:10.1080/02770903.2024.2327036.
[17] SUGIHARTONO T,HIDAYAT A A,LUSIDA A P,et al.Comparison of RDQ and GERDQ for predicting erosive esophagitis in patients with typical GERD symptoms[J].Korean Journal of Gastroenterology,2023,82(2):84-90.DOI:10.4166/KJG.2023.027.
[18] 陈旻湖,李延青,肖英莲,等.中国胃食管反流病诊疗规范[J].胃肠病学,2023,28(10):597-607.DOI:10.3760/CMA.J.CN3113672023062600289.
[19] SIMADIBRATA D M,NGADIONO E,SINURAYA F A G,et al.Diagnostic accuracy of gastroesophageal reflux disease questionnaire for gastroesophageal reflux disease: A systematic review and meta-analysis[J].Neurogastroenterol Motil,2023,35(12):e14619.DOI:10.1111/NMO.14619.
[20] YANG Ying,LIN Jiarong,LI Yique,et al.Effect of body weight and obesity on esophageal function[J].Physiological Research,2023,72(4):14.DOI:10.33549/physiolres.935067.
[21] SUGIHARTONO T,HIDAYAT A A,LUSIDA M A P,et al.Comparison of RDQ and GERDQ for predicting erosive esophagitis in patients with typical GERD symptoms[J].Korean Journal of Gastroenterology,2023,82(2):84-90.DOI:10.4166/KJG.2023.027.
[22] NAPIERALA H,KOPKA M,ALTENDORF M B,et al.Examining the impact of a symptom assessment application on patient-physician interaction among self-referred walk-in patients in the emergency department(AKUSYM): Study protocol for a multi-center, randomized controlled, parallel-group superiority trial[J].Trials,2022,23(1):791.DOI:10.1186/S13063-022-06737-4.
[23] IWAKIRI K,FUJIWARA Y,MANABE N,et al.Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021[J].Journal of Gastroenterology,2022,57(4):267-285.DOI:10.1007/S00535-022-01861-Z.
[24] YADLAPATI R,VAEZI M F,VELA M F,et al.Management options for patients with GERD and persistent symptoms on proton pump inhibitors: Recommendations from an expert panel[J].American Journal of Gastroenterology,2018,113(7):980-986.DOI:10.1038/s41395-018-0045-4.
[25] GRAHAM D Y.Optimal ppidosing for improving gerdsymptoms: Is timing everything?[J].Digestive Diseases and Sciences,2019,64(1):4-6.DOI:10.1007/S10620-018-5418-4.
[26] GYAWALI C P,YADLAPATI R,FASS R,et al.Updates to the modern diagnosis of GERD: Lyon consensus 2.0[J].Gut,2024,73(2):361-371.DOI:10.1136/GUTJNL-2023-330616.
[27] KAHRILAS P,ANASTASIOU F,BREDENOORD A J,et al.Proton pump inhibitors: Rational use and use-reduction-the windsor workshop[J].Digestivediseases,2024,42(3):211-220.DOI:10.1159/000538399.
[28] SASANKAN P,THOTA P N.Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines[J].Cleveland Clinic Journal of Medicine,2022,89(12):700-703.DOI:10.3949/CCJM.89A.22059.
[29] TAI C C,MEDWID S,MCLNTOSH K,et al.Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease[J].Journal of the Canadian Association of Gastroenterology,2024,7(3):238-245.DOI:10.1093/JCAG/GWAD051.
[30] 薛朝军,杜雨晗,靳会欣,等.应用《中国医疗机构药品评价与遴选快速指南》评价富马酸伏诺拉生片[J].中国医院用药评价与分析,2022,22(10):1228-1232.DOI:10.3969/J.ISSN.1672-2124.2022.10.016.
[31] SUGANO K.Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: Safety and clinical evidence to date[J].Therapeutic Advances in Gastroenterology,2018,11:1756283X17745776.DOI:10.1177/1756283X17745776.
[32] WONG N,REDDY A,PATEL A.Potassium-competitive acid blockers:present and potential utility in the armamentarium for acid peptic disorders[J].Gastroenterol Hepatol(NY),2022,18(12):693-700.DOI:10.14309/CRD.0000000000000455.
[33] 朱飞,刘真真,申高飞,等.伏诺拉生治疗反流性食管炎的临床疗效观察[J].中国中西医结合消化杂志,2023,31(10):798-801.DOI:10.3969/J.ISSN.1671-038X.2023.10.08.
[34] FOROOTAN M,ZOJAJI H,EHSANI M J,et al.Advances in the diagnosis of gerdusing the esophageal pH monitoring, gastro-esophageal impedance-pH monitoring, and pitfalls[J].Open Access Macedonian Journal of Medical Sciences,2018,6(10):1934-1940.DOI:10.3889/oamjms.2018.410.
[35] KIM S H.Esophageal mucosal impedance assessment: Clinical usefulness for diagnosis of gastroesophageal reflux disease[J].Journal of Neurogastroenterology & Motility,2024,30(3):253-254.DOI:10.5056/JNM24080.
[36] WONG Mingwei,ROGERS B D,LIU Meixue,et al.Application of artificial intelligence in measuring novel pH-impedance metrics for optimal diagnosis of gerd[J].Diagnostics(Basel),2023,13(5):960.DOI:10.3390/diagnostics13050960.
[37] 肖英莲.世界多地胃食管反流病的共识或指南解读对比[J].上海医学,2022,45(11):745-749.DOI:10.19842/j.cnki.issn.0253-9934.2022.11.003.
[38] LIN Yuqing,LI Yuwen,LIANG Mengya,et al.Acid exposure time > 6% might not improve the therapeutic outcome in chinese gastroesophageal reflux disease patients[J].Journal of Neurogastroenterology and Motility,2021,27(1):55-62.DOI:10.5056/jnm19219.
[39] 周蓉.胃食管反流病不同内镜分型及中医证型与情志因素的相关性研究[D].长沙:湖南中医药大学,2023.DOI:10.27138/d.cnki.ghuzc.2023.000187.
[40] SUYU H,ALISSA J,NORBERT H,et al.24-hour monitoring of transient lower esophageal sphincter relaxation events by long-term high-resolution impedance manometry in normal volunteers: The "mirror phenomenon"[J].Neurogastroenterology & Motility,2019,31(3):e13530.DOI:10.1111/nmo.13530.
[41] PUOTI M G,SAFE M,THAPAR N,et al.The role of high-resolution impedance manometry to identify rumination syndrome in children with unexplained foregut symptoms[J].Journal of Pediatric Gastroenterology and Nutrition,2024,78(5):1082-1090.DOI:10.1002/JPN3.12164.
[42] LOGANATHAN P,GAJENDRAN M,PERISETTI A,et al.Endoscopic advances in the diagnosis and management of gastroesophageal reflux disease[J].Medicina(Kaunas),2024,60(7):1120.DOI:10.1136/bmj.m3786.
[43] VAEZI M F,SIFRIM D.Assessing old and new diagnostic tests for gastroesophageal reflux disease[J].Gastroenterology,2018,154(2):289-301.DOI:10.1053/j.gastro.2017.07.040.
[44] SIMADIBRATA D M,LESMANA E,FASS R.Role of endoscopy in gastroesophageal reflux disease[J].Clin Endosc,2023,56(6):681-692.DOI:10.5946/CE.2023.182.
[45] SHARMA V K.Role of endoscopy in gerd[J].Gastroenterol Clinics of North America,2014,43(1):39-46.DOI:10.1016/j.gtc.2013.12.003.
[46] KURIBAYASHI S,HOSAKA H,NAKAMURA F,et al.The role of endoscopy in the management of gastroesophageal reflux disease[J].DEN Open,2021,2(1):e86.DOI:10.1002/DEO2.86.
[47] 刘敏.糖尿病合并胃食管反流病患者的危险因素分析[D].大连:大连医科大学,2020.DOI:10.26994/d.cnki.gdlyu.2020.000381.
[48] 胡明阳,刘冬.胃食管反流病诊断技术的研究进展[J].北京医学,2022,44(9):823-827.DOI:10.15932/j.0253-9713.2022.09.010.
[49] VISAGGI P,DE BORTOLI N,BARBERIO B,et al.Artificial intelligence in the diagnosis of upper gastrointestinal diseases[J].Journal of Clinical Gastroenterology,2022,56(1):23-35.
[50] LEVINE M S,RUBESIN S E,LAUFER I.Barium studies in modern radiology: Do they have a role?[J].Radiology,2009,250(1):18-22.DOI:10.1097/MCG.0000000000001629.
[51] WANG Bo,SUN Qian,DU Yonghong,et al.Diagnosis and etiological analysis of gastroesophageal reflux disease by gastric filling ultrasound and gerdqscale[J].Journal of Healthcare Engineering,2021,2021:5629067.DOI:10.1155/2021/5629067.
[52] JARUVONGVANICH V,MATAR R,RAVI K,et al.Esophageal pathophysiologic changes and adenocarcinoma after bariatric surgery: Asystematic review and meta-analysis[J].Clin Transl Gastroenterol,2020,11(8):e00225.DOI:10.14309/ctg.0000000000000225.
[53] VAEZI M F.Diagnosing gastroesophageal reflux disease with endoscopic-guided mucosal impedance[J].Gastroenterology & Hepatology,2016,12(4):266-268.DOI:10.1055/S-0038-1634663.
[54] 彭若琳,张振玉.东西方胃食管反流病共识与指南对比解读[J].胃肠病学,2022,27(10):596-600.DOI:10.3969/j.issn.1008-7125.2022.08.001.
[55] DEBI U,SHARMA M,SINGH L,et al.Barium esophagogram in various esophagealdiseases: A pictorial essay[J].Indian Journal of Radiology and Imaging,2019,29(2):141-154.DOI:10.4103/ijri.IJRI_465_18.
[56] MU Kexiao,SUN Qian,LI Xiaoyan,et al.The value of oral contrast-enhanced gastric ultrasonography in the diagnosis and staging of benign peptic ulcer[J].Scientific Reports,2024,14(1):17390.DOI:10.1038/s41598-024-68430-7.
[57] AJMAL S.Contrast-enhanced ultrasonography: Review and applications[J].Cureus,2021,13(9):e18243.DOI:10.7759/CUREUS.18243.
[58] 李博璋,黄越前,丁飞跃,等.胃镜及超声造影在诊断EHH患者中的应用价值比较[J].河北医药,2015,37(20):3122-3124.DOI:10.3969/j.issn.1002-7386.2015.20.029.
[59] TOMITA T,YASUDA T,OKA H,et al.Atypical symptoms and health-related qualityof life of patients with asymptomatic reflux esophagitis[J].Journal of Gastroenterology and Hepatology,2015,30(s1):19-24.DOI:10.1111/jgh.12745.DOI:10.1111/jgh.12745.
[60] MARSCHNER C A,ZHANG L,SCHWARZE V,et al.The diagnostic value of contrast-enhanced ultrasound(CEUS)for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients[J].Clinical Hemorheology and Microcirculation,2020,76(4):453-458.DOI:10.3233/CH-209221.
[61] WANG Shenyun.Application of contrast-enhanced ultrasound in the digestive system[J].Journal of Medical Ultrasound,2018,26(2):65-67.DOI:10.4103/JMU.JMU_33_18.
[62] BURTON L,JOFFE D,MACKEY D W,et al. A transformational change in scintigraphic gastroesophageal reflux studies: A comparison with historic techniques[J].Clinical Physiology and Functional Imaging,2021,41(2):136-145.DOI:10.1111/cpf.12677.
[63] VARDAR R,KESKIN M.Indications of 24 h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophagealmanometry, radiology and scintigraphy in gastroesophageal reflux disease?[J].Turkish Journal of Gastroenterology,2017,28(s1):S16-S21.DOI:10.5152/tjg.2017.06.
[64] MANNING M A,SHAFA S,MEHROTRA A K,et al.Role of multimodality imaging in gastroesophageal reflux disease and its complications, with clinical and pathologic correlation[J].Radiographics,2020,40(1):44-71.DOI:10.1148/rg.2020190029.
[65] LOGANATHAN P,GAJENDRAN M,PERISETTI A,et al.Endoscopic advances in the diagnosis and management of gastroesophageal reflux disease[J].Medicina,2024,60(7):1120.DOI:10.3390/MEDICINA60071120.
[66] CUI Can,YANG Haichun,WANG Yaohong,et al.Deep multimodal fusion of image and non-image data in disease diagnosis and prognosis: A review[J].Progress in Biomedical Engineering,2023,5(2):22001.DOI:10.1088/2516-1091/ACC2FE.
[67] DAVIS T A,GYAWALI C P.Refractory gastroesophageal reflux disease: Diagnosis and management[J].Journal of Neurogastroenterology and Motility,2024,30(1):17-28.DOI:10.5056/jnm23145.
[68] AlZAHRANI M A,ALQARAAWI A M,ALZUBIDE S R,et al.The saudi gastroenterology association consensus on the clinical care pathway for the diagnosis and treatment of GERD[J].Saudi Journal of Gastroenterology,2024,30(6):353-368.DOI:10.4103/sjg.sjg_82_24.
[69] ZYADLAPATI R,GYAWALI C P,PANDOLFINO J E,et al.AGA clinical practice update on the personalized approach to the evaluation and management of gerd: Expert review[J].Clinical Gastroenterology and Hepatology,2022,20(5):984-994.DOI:10.1016/j.cgh.2022.01.025.
[70] ANG D,LEE Y Y,CLARKE J O,et al.Diagnosis of gastroesophageal reflux: An update on current and emerging modalities[J].Annals of the New York Academy of Sciences,2020,1481(1):154-169.DOI: 10.1111/nyas.14369.
[71] ROGERS B D,GYAWALI C P.Enhancing high-resolution esophageal manometry: Use of ancillary techniques and maneuvers[J].Gastroenterology Clinics,2020,49(3):411-426.DOI:10.1016/j.gtc.2020.04.001.
[72] RIBOLSI M,FRAZZONI M,CICALA M,et al.Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with gerd symptoms[J].Neurogastroenterology & Motility,2023,35(1):e14344.DOI:10.1111/nmo.14344.
[73] ZHANG Nan,HAN Ming,ZHENG Qinwei,et al.A scientometrics analysis and visualization of refractory gastroesophageal reflux disease[J].Frontiers in Pharmacology,2024,15:1393526.DOI:10.3389/FPHAR.2024.1393526.
[74] TIAN Yan,ZHANG Weihao,ZHANG Tingting,et al.Analysis of the correlation between dynamic characteristics and symptoms of gastroesophageal reflux disease[J].Surgical Laparoscopy Endoscopy & Percutaneous Techniques,2024,34(3):268-274.DOI:10.1097/SLE.0000000000001187.
[75] SAWADA A,FUJIWARA Y.Belchingdisorders and rumination syndrome: Aliterature review[J].Digestion,2024,105(1):18-25.DOI:10.1159/000534092.
[76] SAWADA A,SIFRIM D.How to recognize and treat rumination syndrome[J].Current Opinion in Gastroenterology,2023,39(4):340-346.DOI:10.1097/MOG.0000000000000937.
[77] PIETER S,S?VERINE V,FREDERIK M,et al.Advanced imaging in gastrointestinal endoscopy: Aliterature review of the current state of the art[J].GE-Portuguese Journal of Gastroenterology,2023,30(3):175-191.DOI:10.1159/000527083.
[78] O’BRIEN P E,HINDLE A,BRENNAN L,et al.Long-term outcomes after bariatric surgery: A systematic review and meta-analysis of weight loss at 10 or more yearsfor all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding[J].Obesity Surgery,2019,29(1):3-14.DOI:10.1007/s11695-018-3525-0.
[79] 中国医师协会消化医师分会胃食管反流病专业委员会.中国高分辨率食管测压临床操作指南(成人)[J].中华消化杂志,2020,40(1):3-8.DOI:10.3760/cma.j.issn.0254-1432.2020.01.002.
[80] JACOBSON J C,PANDYA S R.A narrative review of gastroesophageal reflux in the pediatric patient[J].Translational Gastroenterology and Hepatology,2021,6:34.DOI:10.21037/tgh-20-245.
[81] JESSICA A E,TAHER I O,DAVID J M.Pediatric eosinophilic esophagitis is associated with low baseline impedance[J].Journal of Pediatric Gastroenterology and Nutrition,2022,74(5):621-625.DOI:10.1097/MPG.0000000000003396.
[82] CHEN Xin,DUAN Ruxin,SHEN Yao,et al.Design and evaluation of an intelligent physical examination system in improving the satisfaction of patients with chronic disease[J].Heliyon,2023,10(1):e23906.DOI:10.1016/J.HELIYON.2023.E23906.
[83] FAROOQI M S,PODURY S,CROWLEY G,et al.Noninvasive, multiOmic, and multicompartmental biomarkers of reflux disease: Asystematic review[J].Gastro Hep Advances,2023,2(4):608-620.DOI:10.1016/J.GASTHA.2023.01.014.
[84] GIMMERMAN T Z.Common questions about Barrett esophagus[J].American Family Physician,2014,89(2):92-98.DOI:10.1186/1471-2296-15-12.
[85] GAWRON A J,FRENCH D D,PANDOLFINO J E,et al.Economic evaluations of gastroesophageal reflux disease medical management[J].Pharmacoeconomics,2014,32(8):745-758.DOI:10.1007/s40273-014-0164-8.
[86] ZHOU J,SHRESTHA P,QIU Zhiguan,et al.Distinct microbiota dysbiosis in patients with non-erosive reflux disease and esophageal adenocarcinoma[J].Journal of Clinical Medicine,2020,9(7):2162.DOI:10.3390/jcm9072162.
[87] LIU Yuxin,CHENG Libin,ZHANG Lu,et al.Socioeconomic traits and the risk of Barrett’s esophagus and gastroesophageal reflux disease: A mendelian randomization study[J].World Journal of Gastrointestinal Oncology,2024,16(6):2631-2645.DOI:10.4251/WJGO.V16.I6.2631.
[88] BOBIN F,LECHIEN J R.The role of pH-impedance monitoring in swallowing disorders[J].Current Opinion in Otolaryngology & Head and Neck Surgery,2022,30(6):406-416.DOI:10.1097/MOO.0000000000000841.
[89] 中华医学会消化病学分会.2020年中国胃食管反流病专家共识[J].中华消化杂志,2020,40(10):649-663.DOI:10.3760/cma.j.cn311367-20200918-00558.